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Correspondence: Julian Perelman, Escola Nacional de Saúde Pública, Universidade Nova de Lisboa Av. Padre Cruz, 1600-
560 Lisboa, Portugal, Tel: +351 217 512 100, Fax: +351 217 582 754, e-mail: jperelman@ensp.unl.pt
Background: The European Union (EU) Directive on Patients’ Rights in Cross-border Healthcare clarified the en-
titlements to medical care in other EU Member states. However, little is known about whether EU citizens have
been travelling or are willing to travel to receive care. This study aimed to measure the determinants of cross-
border patient mobility and willingness to travel to receive medical care in the EU, before and after the adoption
of the Directive. Methods: We used individual data from the Eurobarometer 210 (2007) and 425 (2014). In the
2 years, 53 439 EU citizens were randomly selected. We performed a logistic regression on the cross-border patient
mobility and willingness to travel to other EU countries to use healthcare services as a function of the year (2007 or
2014), adjusting for age, gender, education and country size. Results: In 2007, 3.3% of citizens reported cross-
border mobility and 4.6% in 2014. The odds of cross-border patients’ mobility were 11% higher in 2014, compared
with 2007 [odds ratio (OR) 1.11, 95% confidence interval (CI) 1.02–1.21]. Also, mobility was 19% higher in males
(OR 1.19, 95% CI 1.08–1.30) and 20% higher amongst the more educated (OR 1.20, 95% CI 1.09–1.31). However,
the odds decreased 11% per decade of age (OR 0.89 per decade, 95% CI 0.85–0.93) and country size. In 2014, the
willingness to travel decreased by 20% compared with 2007. Conclusions: Cross-border patient mobility is more
likely amongst the younger, the more educated and those from smaller countries. The directive does not seem to
have promoted mobility at a large scale among the neediest citizens.
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Introduction
European Union (EU) law guarantees that every citizen is entitledto preventive healthcare and medical treatment.1 However,
healthcare is an area in which the EU has limited power, i.e. due
to the subsidiarity principle, the competencies remain mainly within
the Member-States. Nevertheless, EU citizens have demanded the
right to freely access other EU health systems since the end of the
90s, which was warranted by decisions of the European Court of
Justice.2 As a result, the negotiations began for the future Directive
2011/24/EU on patients’ rights in cross-border healthcare.
Before 2011 the movement of EU patients to receive healthcare in
another EU country (also known as cross-border patient mobility)
accounted for more than 9.7 billion Euros in healthcare spending
per year.3 The cross-border patient mobility at that time was mainly
due to unplanned care or referrals to other EU healthcare systems by
national providers. Indeed, the cross-border patient mobility can be
planned, for instance, if the patient deliberately travel across the
border to obtain healthcare, or unplanned,4,5 as shown in table 1.
The relevance of cross-border patient mobility is based on the
assumption that the redistribution of supply and demand could
lead to improved safety, quality and efficiency.6–10 Many authors
have sought to describe the barriers and facilitators to cross-border
patient mobility, namely, the proximity of cross-border services (geo-
graphical and those related to language), perceived quality of care,
affordability,4,11 range of the basket of care12,13 and responsiveness.14
Approved in 2011 and transposed to the national law of member
states in 2013, the Directive 2011/24/EU on patients’ rights in cross-
border facilitated cross-border healthcare healthcare, although it did
not create new entitlements, the Directive clarified the rights of
patients to seek reimbursement for healthcare received in another
Member-State.15 Simply stated, an EU citizen who goes to another
country to purchase healthcare available in his home country should
be covered by the home-country health insurance. The clarification
of the entitlements made the reimbursement of health expenses in
another Member-State more predictable and clarified the basket of
care in the EU countries.16–18
However, some restrictions in the Directive were implemented,
i.e. prior authorisations for hospitalisations that require an
overnight stay and highly specialised, cost-intensive healthcare.
On top of that, some countries required slightly different prior au-
thorisation procedures.19,20 This complex navigation framework can
act by itself as a barrier to cross-border patient mobility.
To the best of our knowledge, no study has measured how patients
(and which patients) may have changed their willingness to travel for
healthcare following the implementation of the Directive. In this
study, we measured the cross-patient mobility and its determinants
before and after the implementation of the Directive. By doing so, we
expect to highlight the extent to which the Directive has been
successful in enhancing patient mobility across Europe, while the
analysis of determinants will help identify which sub-populations
should be targeted to improve the mobility patterns.
Methods
Data sources and study design
We used primary data from the flash Eurobarometer 210 (2007)21
and the special Eurobarometer 425 (2014)22 obtained through
the Leibniz-Institute for the Social Sciences (GESIS). The
Eurobarometer’s repeated cross-section surveys covered participants
from the EU Member-States, and each national sample was repre-
sentative of the population aged 15 years and over. Participants were
sampled using a multistage random sampling design based on
country-specific population size. In 2007, the mode of data
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collection was mainly through computerised assisted telephone
interviews (70% of the sample) and the rest were face-to-face
interview. For 2014, the mode of data collection was only face-to-
face interview by computer assisted personal interviews. All variables
were self-reported. The interviewer indicated the Country of
residence; the study team recoded West and East-Germany into
Germany and England and Northern Ireland into the UK.
Detailed methods of the surveys’ methodology can be found
elsewhere.23 The European Commission was responsible for the
approval of the study protocols, and informed consent was
obtained from all participants. The information was anonymised
and de-identified before analysis.
Study outcomes
We studied two main outcomes: (i) if the participants had received
medical care outside of their residency country over the 12 months
preceding the interview, hereinafter called ‘cross-border patient
mobility’ and (ii) if the participants were willing to travel to
another EU state to receive medical care, hereinafter called ‘willing-
ness to travel’. The questions related to these outcomes were asked in
the same way as in both Eurobarometer 210 (2007) and 425 (2014)
‘Have you received any medical treatment in another EU country in
the last 12 months?’. The ‘cross-border patient mobility’ was coded
as a binary variable, ‘yes’ or ‘no’. The question on willingness to
travel, ‘Would you be willing to travel to another EU country to
receive medical treatment?’, included three responses, ‘yes’, ‘no’ and
‘depends’. We coded the willingness to travel for healthcare as a
binary variable, assimilating the ‘depends’ answer to an affirmative
answer.
Explanatory variables
Age, gender, education, employment status and country size were
included as explanatory variables, following earlier contributions on
patient mobility.6,5,24 Age was measured in years and used as a
continuous variable; however, to facilitate the interpretation, the
odds ratio (OR) was presented in 10-year intervals. Education was
a three-category variable, which indicated the age at which the
person concluded her/his education: ‘less than 15 years old’, ‘more
than 15 years-old’ or ‘still studying’. Employment status was divided
into ‘working’, ‘retired’ and ‘not working’ (unemployed and
students) categories. The country size was defined as the
population size weight of the country based on the resident
population, used by the Eurobarometer Survey, and the countries
were then aggregated in population weight tertiles (large, medium
and small countries). As there is no consensus about the definition
of country sizes in the EU we decided to use population weights
tertiles as a cut-off measure.
Sensitivity analysis
First, to account for potential misclassification of the ‘willingness to
travel’ variable related to the decision to classify respondents who
answered ‘depends’ as willing to travel, we replicated the models
classifying people answering ‘depends’ as not willing to travel.
Second, to address the possible confounding effect attributable to
not having information about health status, we used the bad and
very bad self-perceived health (SPH) data from the European Survey
on Income and Living Conditions (EU-SILC) for the years 2007 and
2014. We calculated the prevalence of ‘bad’ and ‘very bad’ SPH by
country, age group, gender and employment status. This aggregate
determinant was attributed to each observation from the
Eurobarometer according to its country, age group, gender and
employment status. The models were replicated adjusting for this
group-specific prevalence of bad and very bad SPH.
Statistical methods
We used Chi-square tests to compare frequency distributions for
categorical variables, and t-tests were used to compare the means
of continuous variables (age). All proportions and means were
weighted according to sampling weights.
We then pooled the data for 2007 and 2014 and performed a
logistic regression on the cross-border patient mobility and willing-
ness to travel to other EU countries. We modelled these outcomes as
a function of the year (2007 or 2014), age, gender, education and
country size.
Age was tested in the model in square root, quadratic and cubic
function to check for non-linear behaviour. The missing data were
not incorporated into the models. The population size weighting
factors correct for the fact that most countries have almost
identical sample sizes (n = 1000), no matter how large or small
their populations are, these weights were applied to determine per-
centages in descriptive analysis and in the multivariate analyses.
For the statistical analysis, we used Stata 13.
Results
The sample included 55 096 observations from all EU countries.
After elimination of observations with missing data, the sample
was reduced to 53 439 observations (3% of the sample was
removed), distributed by 48.2% of the respondents in 2007 and
51.8% in 2014.
Table 2 shows the baseline characteristics of the population.
The mean age is 48 years old and 56% are female. More than half
of the interviewed were working, and 77% were from large European
countries. Overall, interviewees who received medical care abroad
(cross-border patient mobility) were younger (mean age 45.3 years),
more likely to be male (4.5 vs. 3.5% in women), more educated (4.6
vs. 3.5% stopped studying after 15 years old). Also, retired individ-
uals (3.3 vs. 4.4% working) and those from large countries (3.0 vs.
4.4% in small countries) received less medical care abroad. A very
similar pattern was observed for the willingness to travel.
Cross-border patient mobility
Considering the whole sample, 4.0% engaged in cross-border patient
mobility, which increased from 3.3% in 2007 to 4.6% in 2014.
Nevertheless, the absolute values remained low. In the unadjusted
Table 1 Reasons to seek cross-border medical care in the EU
Holidays/work
trips
EU citizens who need to use the healthcare services on holidays in another EU/EEA country, or citizens who are on a work trip abroad in
another EU/EEA country
Retirement EU citizens who retired to a different country and want to use the healthcare system where they currently live
Border regions EU citizens who live in border regions and share cultural and linguistic characteristics of the region in another EU country, and who want
to use the healthcare service closer to home, which might be on the other side of the border
Perceived
advantages
EU citizens who seek cross-border healthcare due to perceived advantages of the system in another EU country, related to the price (out of
pocket), comprehension of the basket of care, quality of the services or access (waiting times)
Health system
incapacity
EU citizens who are sent abroad by their health systems to overcome capacity or expertise shortage at the national system. It concerns
mainly smaller countries or regions with low population density
Adapted from ‘Health Care Provision and Patient Mobility, by Rosenmöller M, McKeee M, Baeten R, Glinos I. Springer. 2006’.
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analysis, some factors favoured the cross-border patient mobility,
among which gender and education were the most notable (table 3).
In the adjusted analysis, males had a 19% increased likelihood of
crossing borders when compared with women (OR 1.19 95%
confidence interval (CI) 1.08–1.30). The EU citizens who stopped
studying at age 15 years old or older had a 20% greater likelihood of
cross-border patient mobility (OR 1.20 95% CI 1.09–1.31), when
compared with those who stopped at 15 years old or younger. In the
year 2014, there was an 11% increase in the likelihood of having
received medical care abroad when compared with the year 2007
(OR 1.11 95% CI 1.02–1.21).
However, some determinants seem to hinder the cross-border
patient mobility, corresponding to: older age, with an 11%
decrease in the odds per decade (OR 0.89, 95% CI 0.85–0.93) and
being from a medium (OR 0.84 95% CI 0.76–0.93) or large country
(OR 0.78 95% CI 0.65–0.93). The employment and student status
lost their significance in the adjusted model.
Willingness to travel to receive medical care
The willingness to travel to receive medical care fell from 2007 to
2014. Contrasting with the cross-border patient mobility low
prevalence, the percentage of citizens willing to travel is high,
55.0% in 2007 and 48.5% in 2014. In 2014, 3.2% stated willingness
to travel to receive healthcare would depend on the country’s
provision of care, and 12.7% said it would depend on the type of
treatment (data not shown in tables).
In the unadjusted model, the willingness to travel was significantly
and positively associated with being male, more educated, in school
and not working, while a significant negative association was
observed for age, retired status and living in a non-large country
(table 3).
In the adjusted model, the determinants that favoured the will-
ingness to travel were being male (OR 1.07, 95% CI 1.01–1.08),
being a non-worker (OR 1.07 95% CI 1.05–1.20), having stopped
studying at 15 years or older (OR 1.32 95% CI 1.26–1.37) and being
from a large country (OR 1.54 95% CI 1.43–1.66) (table 4).
Some determinants in the adjusted model were barriers to the
willingness to travel to receive medical care, such as older age (per
10 years) (OR 0.86 95% IC 0.84–0.87), being a student (OR 0.87
95% CI 0.80–0.96) or retired (OR 0.72 95% CI 0.68–0.76) and
being from a medium country (OR 0.83 95% CI 0.80–0.87). The
willingness to travel was significantly lower in 2014, as compared
with 2007 (OR 0.80 95% CI 0.77–0.82).
Sensitivity analysis
In the model in which we categorised the ‘depends’ response as not
willing to travel, the signal and significance of the year estimate were
not altered. However, the 2014 reduction in willingness to travel
changed from 20 to 59% (Supplementary table S1).
After the adjustment for self-reported health, most point estimates
remained stable in significance and magnitude, namely year, age and
gender. The significant major change was that people from large
countries reported a lower willingness to travel, contrary to the
model without self-reported health (Supplementary table S1).
Discussion
Key findings
We conducted a study seeking to identify the determinants of cross-
border patient mobility and the willingness to travel to receive
medical care in the EU using data from interviews of two
Eurobarometer surveys. We found that between 2007 and 2014
there was an increase in cross-border mobility (+15%) and a
decrease in willingness to travel to receive medical care (20%).
This decrease was much more pronounced when people who
answered ‘depends’ on the willingness to travel question were
classified as not willing to travel (59%). Additionally, older
people were less likely to seek medical care across the border
(11% per decade) and less willing to receive medical care in
another EU country (14% per decade). More educated EU
citizens were more likely to seek healthcare abroad (+20%) and
more willing to travel to receive care (+32%). The larger the
country of residence, the less likely the use of cross-border
medical care. Furthermore, men engaged more in cross-border
medical care (+20%) and were more likely to be willing to seek
medical care in another EU country (+7%).
Interpretation
The literature that compares cross-border mobility or willingness to
travel in the EU is scarce. In a small survey in Malta, Busuttil et al.25
found similar determinants of willingness to travel. Also, there are
no other regions of the globe with similar cross-border healthcare
frameworks. For the USA, estimates of planned cross-border patient
mobility vary between 1 and 1.5%,26 although it can go up to 37% in
the Mexican border region.27
Regarding the determinants of cross-border mobility and willing-
ness to travel, one could hypothesise that younger patients are more
likely to cross a border to seek medical care due to their greater
facility to overcome some barriers such as language, as most
younger people can communicate in a common language
(English).28,29 The learning-by-doing effect might play a role as
well, i.e. younger people who have already travelled to another
Member-State for other purposes (e.g. Erasmus and DaVinci
programmes) may be more likely to have experienced a foreign
health system within the EU,30 thereby being keener to engage in
cross-border patient mobility.
To the best of our knowledge, the greater likelihood of males to
travel for care has never been documented. We know, however, that
men are also more likely (22%) to envisage working abroad in the
EU, possibly in line with our results.31





N = 53 439 N = 2354 N = 30 243
Year
2007 48.2 3.3 55.0
2014 51.8 4.6 48.5
Age mean(SD) 48.1 (17.9) 45.3 (17.9) 45.0 (16.8)
Gender
Male 43.6 4.5 53.2
Female 56.4 3.5 50.2
Education (age when stopped)
Less than 15 60.4 3.5 47.5
More than 15 31.9 4.6 57.0
Still studying 7.7 4.4 63.3
Employment
Working 54.0 4.4 55.8
Not working 18.8 3.9 59.3
Retired 27.2 3.3 37.7
Country size
Small 5.5 4.4 57.1
Medium 16.8 4.2 53.8
Large 77.7 3.0 50.7
Notes: all the percentages and means presented were weighted to
be representative of the EU population. For categorical variables, a
Chi-square test was performed in comparisons; for continuous
variables (age), a t-test was performed. The P values report to com-
parisons made with each category,
: P values < 0.001.
Small size countries—LU; DK; IE; FI; CY; EE; LV; LT; MT; SI; HR;
medium size countries: BE; GR; PT; SE; AT; CZ; HU; SK and large
size countries: FR, NL; DE; IT; UK; ES; PL; RO.
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Higher levels of education are not a surprising determinant of
cross-border patient mobility and willingness to travel. More years
of education entail a better understanding of rights and more
demanding expectations of the healthcare system.25,32
Interestingly, employment status does not play a role in cross-
border patient mobility. Working people with a steady income
were expected to be more likely to be able to afford travel for
care. However, our employment categories were possibly too
broad and heterogeneous to capture differences in socio-economic
conditions. The ‘employed’ category, in particular, may encompass
very different occupations, social positions and incomes. It is
surprising, however, that individuals not working would be more
likely to be willing to travel for care. The not working condition may
be associated with unmeasured health problems, possibly explaining
this finding. Moreover, working individuals might find more
difficult to take days off than non-workers to travel abroad.
The greater mobility by people from smaller countries may be
explained by the possibly lower provision of highly specialised
care, which is more profitable in large countries facing a greater
demand.33 People in smaller countries also face lower travel
distance to reach a neighbouring country. The most obvious
example is Luxembourg, where 18% of people seek care abroad.22
The distance explanation may be the most plausible, as we observe
that people from larger countries are more willing to travel but less
likely to do so. In other terms, people from larger countries may also
face unmet needs creating a willingness to travel, which is not
satisfied because of geographical barriers.
The increase in mobility combined with a decrease in the willing-
ness to travel could mean that some unmet needs were covered by
seeking medical care abroad. Some authors claim that cross-border
patient mobility could redistribute supply and demand towards a
better provision of care regarding safety, quality and efficiency.2
Also, the decrease in the willingness to travel to seek care abroad
could mean that unmet needs within the country were reduced
following the Directive. Indeed, some literature reports that the
Directive was an opportunity to implement reforms10 including le-
gislation on patients’ rights,16,17 the definition of health benefits
package and compulsory indemnity insurance, however, although
with variations across countries,34 it seems thus that the Directive
had positive spillovers.
Despite the 1.3 percentage point increase in cross-border patient
mobility in 2014, the absolute numbers remain low. Even with the
implementation of the Directive, we are far from a dynamic EU
health market. In the process of engaging in cross-border patient
Table 3 Determinants of cross-border patient mobility and willingness to travel in the EU, unadjusted model
Cross-border patient mobility Willingness to travel
Odds ratio P value 95% CI Odds ratio P value 95% CI
Year 2014 (2007 reference) 1.11 0.001 1.02–1.21 0.80 0.001 0.77–0.82
Age (per 10 years) 0.90 0.001 0.88–0.92 0.82 0.001 0.81–0.83
Gender (male) 1.20 0.001 1.10–1.30 1.05 0.05 1.01–1.08
Education (age when stopped)
Less than 15 1(ref.) 1(ref.)
More than 15 1.30 0.001 1.20–1.40 1.50 0.01 1.40–1.60
Still studying 1.30 0.001 1.10–1.50 1.70 0.01 1.60–1.80
Employment
Working 1(ref.) 1(ref.)
Not working 0.96 >0.05 0.86–1.10 1.10 0.01 1.05–1.2
Retired 0.72 0.001 0.65–0.80 0.50 0.01 0.46–0.52
Country size
Small 1(ref.) 1(ref.)
Medium 0.84 0.001 0.75–0.92 0.74 0.01 0.71–0.77
Large 0.79 0.001 0.71–0.87 0.77 0.01 0.74–0.81
Notes: small countries—LU; DK; IE; FI; CY; EE; LV; LT; MT; SI; HR; medium size countries: BE; GR; PT; SE; AT; CZ; HU; SK and large size
countries: FR, NL; DE; IT; UK; ES; PL; RO.
Table 4 Determinants of cross-border patient mobility and willingness to travel in the EU, fully adjusted model
Cross-border patient mobility Willingness to travel
Odds ratio P value 95% CI Odds ratio P value 95% CI
Year 2014 (2007 reference) 1.11 0.001 1.02–1.21 0.80 0.001 0.77–0.82
Age (per 10 years) 0.89 0.001 0.85–0.93 0.86 0.001 0.84–0.87
Gender (male) 1.19 0.001 1.08–1.30 1.07 0.01 1.01–1.08
Education (age when stopped)
Less than 15 1(ref.) 1(ref.)
More than 15 1.20 0.001 1.09–1.31 1.32 0.01 1.26–1.37
Still studying 0.86 >0.05 1.10–1.50 0.87 0.01 0.80–0.96
Employment
Working 1(ref.) 1(ref.)
Not working 1.01 >0.05 0.88–1.17 1.07 0.05 1.05–1.2
Retired 1.02 >0.05 0.65–1.16 0.72 0.001 0.68–0.76
Country size
Small 1(ref.) 1(ref.)
Medium 0.84 0.001 0.76–0.93 0.83 0.01 0.80–0.87
Large 0.78 0.01 0.65–0.93 1.50 0.01 1.40–1.60
Notes: small countries—LU; DK; IE; FI; CY; EE; LV; LT; MT; SI; HR; medium size countries: BE; GR; PT; SE; AT; CZ; HU; SK and large size
countries: FR, NL; DE; IT; UK; ES; PL; RO.
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mobility, the willingness to travel is the first stage. One could
consider the willingness to travel as the maximum stock of the
population that may travel; therefore, only a 10th of those who
are willing to travel actually engage in cross-border patient
mobility. The small relative increase in the recent years could be
influenced by the financial, economic and social crisis in Europe.
Cross-border mobility under the new Directive demands consider-
able out-of-pocket expenditures because the reimbursement of
expenses is done after the provision of services. Adverse economic
circumstances could, thus, have a negative impact on cross-border
patient mobility. However, cross-border mobility to countries where
the cost of care is significantly lower must always be considered as a
potential motivation, despite all the barriers. Time may also play an
important role, since the Directive came into force only 1 year before
the second survey, giving little time for the information to permeate
into health systems and to the general public knowledge.
Strengths and limitations
This study is to the best of our knowledge the first to quantify the
determinants of cross-border patient mobility and the willingness to
travel to receive medical care, at the EU level. We were able to
demonstrate empirically what was earlier theorised,4 that citizens
from larger countries, which can concentrate more healthcare
resources are less likely to seek medical care abroad.
This study has some limitations. First, the surveys in 2007 and
2014 had some differences in the methodology applied. In 2007, the
survey used mainly telephone interviews, which might lead to some
selection bias towards participants who spend more time at home
(retired, unemployed), with a lower purchasing power, and therefore
less likely to seek medical care abroad. In 2014, all interviews were
done face-to-face. These different methods might overestimate the
difference in cross-border mobility between the 2 years. Although
this might affect the estimate of the ‘Year’ determinant, it is unlikely
to influence the other determinants.
Also, the causal pathway from socio-demographic determinants to
cross-border mobility could not be adequately assessed, which
would require information about unmet medical needs, affordability
of care and perceived medical quality. However, our study was a first
assessment of determinants of cross-border mobility, distinguishing
which sub-populations travel or are willing to travel. This is valuable
information for decision-making, although more detailed surveys
are necessary for a complete understanding of the phenomenon.
Another limitation is related to the inability to stratify patient
mobility into planned and unplanned. In the 2014 survey, this strati-
fication was possible but in 2007 the stratified data were not
available. That could be seen as a limitation because planned and
unplanned medical care might have different determinants. Hence,
planned or unplanned care might act as an effect modifier. The
European Commission reports that 40% of all the cross-border
patient mobility is planned.
Future research
One of the most exciting aspects to study in the future is the rela-
tionship between health condition, unmet needs, cross-border
patient mobility and the willingness to seek medical care abroad.
Whether the current EU legislation effectively protects the EU
citizens from constraints in the country health systems generating
unmet needs is unknown.
Conclusion
Our study demonstrates that being younger, male, more educated
and from a small country increases the likelihood of engaging in
cross-border patient mobility and that this mobility, although
remaining at very low levels, increased in Europe between 2007
and 2014, following the implementation of the patients’ rights in
cross-border healthcare Directive. The weak and socially patterned
rate of cross-border patient mobility indicates that we are far from a
European healthcare market, whose potential benefits are within
reach. Policy-makers should consider changes to promote the
directive among European decision-makers and populations, with
a particular focus on the neediest and most vulnerable.
Supplementary data
Supplementary data are available at EURPUB online.
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Key points
 Being younger, male, more educated and from a small
country increases the likelihood of engaging in cross-
border patient mobility.
 Patient mobility, although remaining at very low levels,
increased in Europe between 2007 and 2014.
 The 2011 cross-border Directive does not seem to have
promoted patient mobility on a large scale.
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